3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
8
Sarcoma
2
Neoplasms
2
Neoplasm Metastasis
2
Multi-centric Castleman's Disease
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Peritoneal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphadenopathy
1
Liposarcoma
1
Leiomyosarcoma
1
Hodgkin Disease
1
Histiocytoma, Malignant Fibrous
1
HIV Infections
1
Gliosarcoma
1
Glioblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Endometrial Neoplasms
1
Interventions
Gemcitabine
17
Magnetic Resonance Spectroscopy
16
Specimen Handling
15
Cisplatin
12
pembrolizumab
11
enfortumab vedotin
7
Mitomycin
7
Cystoscopy
7
durvalumab
5
avelumab
5
Transurethral Resection of Bladder
5
Radiation
5
Fluorouracil
5
Carboplatin
5
Biopsy
5
Radiotherapy
4
Nivolumab
4
Cystectomy
4
tremelimumab
3
erdafitinib
3
dehydroftorafur
3
cabozantinib
3
atezolizumab
3
Platinum
3
Mitozytrex
3
Immunoglobulin G
3
Disulfides
3
1,2-diaminocyclohexaneplatinum II citrate
3
ulixertinib
2
sapanisertib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
liposomal doxorubicin
×
30 days
×
Clear all
No trials found.